223
Participants
Start Date
February 25, 2023
Primary Completion Date
January 17, 2024
Study Completion Date
January 17, 2024
NRCT-101-SR
NRCT-101SR is a sustained release formulation. Subjects ≥ 50 kg LBM receive a total of four 500 mg tablets/day and subjects \< 50kg LBM receive a total of four 375 mg tablets per day.
Placebo
Matching placebo
Coastal Carolina Research Center - North Charleston, North Charleston
Accel Research Sites, Maitland
Miami Dade Medical Research Institute, Miami
Accel Research Sites, Lakeland
Velocity Clinical Research - Meridian, Meridian
Center for Psychiatry and Behavioral Medicine, Las Vegas
Collaborative Neuroscience Network, Garden Grove
Alcanza Clinical Research Company, Boston
Hassman Research Institute, Berlin
Lead Sponsor
Neurocentria, Inc.
INDUSTRY